XML 53 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details) - USD ($)
$ in Millions
 3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net $ 2 $ 2
Exit and other-related costs 22 21
Asset impairments and accelerated depreciation 28 0
Total 52 23
Operating Segments | U.S. Pharmaceutical    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 1 3
Exit and other-related costs 1 1
Asset impairments and accelerated depreciation 0 0
Total 2 4
Operating Segments | Prescription Technology Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 2 2
Asset impairments and accelerated depreciation 0 5
Total 2 7
Operating Segments | Medical-Surgical Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 2 1
Asset impairments and accelerated depreciation 0 0
Total 2 1
Operating Segments | International    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 5 2
Asset impairments and accelerated depreciation 1 0
Total 6 2
Corporate    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 1 (1)
Exit and other-related costs 12 15
Asset impairments and accelerated depreciation 27 (5)
Total $ 40 $ 9